New program aims to lower cholesterol in blood donors with genetic condition

NCT ID NCT05693701

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tests a program to help blood donors who have familial hypercholesterolemia (a genetic condition causing very high cholesterol) get proper treatment. One hundred participants will either receive standard notification about their condition or a bundle of extra support, including educational materials and a care navigator. The goal is to see if the extra support leads to lower LDL cholesterol levels after six months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Implementation Strategy Bundle (behavioral intervention)
What this could lead to
If successful, this could provide a practical way to help people with inherited high cholesterol get their levels under control and reduce heart disease risk.
What could go wrong
This is a small, early-stage study focused on implementation, not a new drug. Results may not apply to everyone, and the intervention may not lead to lasting cholesterol improvements.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FAMILIAL HYPERCHOLESTEROLEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

familial hypercholesterolemia Hypercholesterolemia inherited lipid metabolism disorder Lipid Metabolism Disorders

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • UT Southwestern Medical Center

    RECRUITING

    Dallas, Texas, 75390, United States

    Contact Email: •••••@•••••

    Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.